Clinical trial
A Study on the Effect of Kidney Disease on a Diabetes Medication (0431-008)
NCT00418366 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00418366 |
|---|---|
| Title | A Study on the Effect of Kidney Disease on a Diabetes Medication (0431-008) |
| Official title | An Open- Label, 2 Part Study to Investigate the Pharmacokinetics, Safety, and Tolerability of MK0431(Sitagliptin Phosphate) in Patients With Varying Degrees of Renal Insufficiency |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Renal Insufficiency, Hemodialysis |
| Intervention type | Drug |
| Interventions | MK0431, sitagliptin phosphate / Duration of Treatment : 1 Days |
| Enrollment | 24 |
| Start date | Jan 1, 2003 |
| Primary completion | Mar 1, 2003 |
| Completion | Mar 1, 2003 |
| First posted | Jan 4, 2007 |
| Last update posted | Aug 19, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: